» Articles » PMID: 24253288

The Role of Monogamy and Duration of Heterosexual Relationships in Human Papillomavirus Transmission

Overview
Journal J Infect Dis
Date 2013 Nov 21
PMID 24253288
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background:  Published data are equivocal about the relative rates of male-to-female and female-to-male human papillomavirus (HPV) transmission. Our objective was to estimate genital HPV incidence among heterosexual partners from a broad age range and to investigate the effects of monogamy and relationship duration on incidence.

Methods:  HPV genotyping was conducted for heterosexual partners, aged 18-70 years, from Tampa, Florida, who provided genital exfoliated cell specimens at semiannual visits during a 2-year study. The rate of incident HPV detection was assessed for 99 couples, and transmission incidence was estimated among a subset of 65 discordant couples. We also evaluated the effect of monogamy and relationship duration on transmission incidence.

Results:  Couples were followed up for a median of 25 months and had a mean age of 33 years for both sexes. The HPV type-specific transmission incidence rate was 12.3 (95% confidence interval, 7.1-19.6) per 1000 person-months for female-to-male transmission and 7.3 (95% confidence interval, 3.5-13.5) per 1000 person-months for male-to-female transmission. Regardless of monogamy status or relationship duration, there was a similar pattern of increased incident HPV detection among men compared with women.

Conclusions:  HPV may be transmitted more often from women to men than from men to women, suggesting a need for prevention interventions, such as vaccination, for men.

Citing Articles

Behaviors and willingness to support HPV vaccination for women: a cross-sectional study of young adult men in China.

Wang W BMC Public Health. 2024; 24(1):3429.

PMID: 39695520 PMC: 11654176. DOI: 10.1186/s12889-024-20944-5.


The role of personal health beliefs and altruistic beliefs in young Chinese adult men's acceptance of the human papillomavirus vaccine.

Wang W Sci Rep. 2024; 14(1):20341.

PMID: 39242754 PMC: 11379873. DOI: 10.1038/s41598-024-71494-0.


Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.

Diakite I, Martins B, Owusu-Edusei K, Palmer C, Patterson-Lomba O, Gomez-Lievano A Infect Dis Ther. 2024; 13(5):965-990.

PMID: 38589763 PMC: 11098984. DOI: 10.1007/s40121-024-00952-z.


The Immune Response Generated against HPV Infection in Men and Its Implications in the Diagnosis of Cancer.

Chihu-Amparan L, Pedroza-Saavedra A, Gutierrez-Xicotencatl L Microorganisms. 2023; 11(6).

PMID: 37375112 PMC: 10301280. DOI: 10.3390/microorganisms11061609.


Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma - A review.

Wierzbicka M, San Giorgi M, Dikkers F Rev Med Virol. 2022; 33(1):e2337.

PMID: 35194874 PMC: 10078185. DOI: 10.1002/rmv.2337.


References
1.
Mbulawa Z, Johnson L, Marais D, Coetzee D, Williamson A . The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples. J Infect. 2013; 67(1):51-8. DOI: 10.1016/j.jinf.2013.03.009. View

2.
Tuite A, Fisman D . Spectrum bias and loss of statistical power in discordant couple studies of sexually transmitted infections. Sex Transm Dis. 2010; 38(1):50-6. DOI: 10.1097/OLQ.0b013e3181ec19f1. View

3.
Giuliano A, Lazcano-Ponce E, Villa L, Flores R, Salmeron J, Lee J . The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):2036-43. PMC: 3471778. DOI: 10.1158/1055-9965.EPI-08-0151. View

4.
Dunne E, Unger E, Sternberg M, McQuillan G, Swan D, Patel S . Prevalence of HPV infection among females in the United States. JAMA. 2007; 297(8):813-9. DOI: 10.1001/jama.297.8.813. View

5.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F . A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2. DOI: 10.1016/s1470-2045(09)70096-8. View